Cancer Genetics

St. Jude Releases Medulloblastoma Risk Model and MB‑Meta Portal to Enable Treatment De‑Escalation

A new St. Jude analysis of nearly 900 cases suggests many children could receive gentler therapy without sacrificing survival.